A Study Evaluating MM-310 in Patients With Solid Tumors

Clinical trial NCT03076372 · UNKNOWN

Trial details

NCT number: NCT03076372
Sponsor: Merrimack Pharmaceuticals
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumors Urothelial Carcinoma Gastric Carcinoma Squamous Cell Carcinoma of the Head and Neck Ovarian Cancer Pancreatic Ductal Adenocarcinoma Prostate Adenocarcinoma Non-small Cell Lung Cancer Small Cell Lung Cancer Triple Negative Breast Cancer Endometrial Carcinoma Soft Tissue Sarcoma

Start date: 2017-02-22
Primary completion: 2018-06-01
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.